Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells
Apstrakt
Cisplatin analogues, cis-dichloro(ethylenediamine-N,N'-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N'-di-3-propanoic acid) platinum(II) (2), as well as trans-dichloro(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N'-diacetato)platinum(IV) (5) and trans-dibromo(propylenediamine-N,N'-diacetato)platinum(IV) (6), -([Pt(H(2)eddp)Cl(2)], [Pt(Heddp)I], trans-[Pt(eddp)Cl(2)], trans-[Pt(eddp)Br(2)], trans-[Pt(pdda)Cl(2)] and trans-[Pt(pdda)Br(2)], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin.
Ključne reči:
platinum(IV) / platinum(II) / edda / adenocarcinoma HeLa / cytotoxicityIzvor:
Journal of Coordination Chemistry, 2006, 59, 7, 815-819Izdavač:
- Taylor & Francis Ltd, Abingdon
DOI: 10.1080/00958970500404708
ISSN: 0095-8972
WoS: 000237854200013
Scopus: 2-s2.0-33646883528
Kolekcije
Institucija/grupa
Hemijski fakultet / Faculty of ChemistryTY - JOUR AU - Kaluđerović, Goran N. AU - Dinovic, Vesna M. AU - Juranić, Zorica D. AU - Stanojković, Tatjana AU - Sabo, Tibor PY - 2006 UR - https://cherry.chem.bg.ac.rs/handle/123456789/780 AB - Cisplatin analogues, cis-dichloro(ethylenediamine-N,N'-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N'-di-3-propanoic acid) platinum(II) (2), as well as trans-dichloro(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N'-diacetato)platinum(IV) (5) and trans-dibromo(propylenediamine-N,N'-diacetato)platinum(IV) (6), -([Pt(H(2)eddp)Cl(2)], [Pt(Heddp)I], trans-[Pt(eddp)Cl(2)], trans-[Pt(eddp)Br(2)], trans-[Pt(pdda)Cl(2)] and trans-[Pt(pdda)Br(2)], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin. PB - Taylor & Francis Ltd, Abingdon T2 - Journal of Coordination Chemistry T1 - Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells VL - 59 IS - 7 SP - 815 EP - 819 DO - 10.1080/00958970500404708 ER -
@article{ author = "Kaluđerović, Goran N. and Dinovic, Vesna M. and Juranić, Zorica D. and Stanojković, Tatjana and Sabo, Tibor", year = "2006", abstract = "Cisplatin analogues, cis-dichloro(ethylenediamine-N,N'-di-3-propanoic acid)platinum(II) (1) and cis-iodo(ethylenediamine-N,N'-di-3-propanoic acid) platinum(II) (2), as well as trans-dichloro(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (3), trans-dibromo(ethylenediamine-N,N'-di-3-propanoato)platinum(IV) (4), trans-dichloro(propylenediamine-N,N'-diacetato)platinum(IV) (5) and trans-dibromo(propylenediamine-N,N'-diacetato)platinum(IV) (6), -([Pt(H(2)eddp)Cl(2)], [Pt(Heddp)I], trans-[Pt(eddp)Cl(2)], trans-[Pt(eddp)Br(2)], trans-[Pt(pdda)Cl(2)] and trans-[Pt(pdda)Br(2)], respectively) were used to assess antitumor selectivity against human adenocarcinoma HeLa cells. The results show that different oxidation states of platinum, different halide ligands, chelating aminocarboxylato and diamine backbones have similar effects with edda-type ligands and activity is lower than for cisplatin.", publisher = "Taylor & Francis Ltd, Abingdon", journal = "Journal of Coordination Chemistry", title = "Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells", volume = "59", number = "7", pages = "815-819", doi = "10.1080/00958970500404708" }
Kaluđerović, G. N., Dinovic, V. M., Juranić, Z. D., Stanojković, T.,& Sabo, T.. (2006). Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells. in Journal of Coordination Chemistry Taylor & Francis Ltd, Abingdon., 59(7), 815-819. https://doi.org/10.1080/00958970500404708
Kaluđerović GN, Dinovic VM, Juranić ZD, Stanojković T, Sabo T. Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells. in Journal of Coordination Chemistry. 2006;59(7):815-819. doi:10.1080/00958970500404708 .
Kaluđerović, Goran N., Dinovic, Vesna M., Juranić, Zorica D., Stanojković, Tatjana, Sabo, Tibor, "Activity of some platinum(II/IV) complexes with edda-type ligands against human adenocarcinoma HeLa cells" in Journal of Coordination Chemistry, 59, no. 7 (2006):815-819, https://doi.org/10.1080/00958970500404708 . .